TRIM72 and tongue cancer: Evidence suggesting that MG53 may perform an anticancer role in cancers, such as hepatocellular carcinoma, colorectal carcinoma, tongue cancer, and nonsmall cell lung cancer (NSCLC), has recently emerged (17–20).